Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Report Of Exempt Distribution.

Apr 16, 2024 03:39PM

Nextblockbuster

Apr 16, 2024 07:13PM

Apr 16, 2024 07:45PM

jonzobot

Apr 17, 2024 03:58PM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Report Of Exempt Distribution.

in response to

jonzobot

posted on Apr 17, 2024 04:17PM

The Hepalink Debenture is a Resverlogix liability, not Zenith's.

The exempt distribution is in favour of Zenith, although I'm sure some of the funds will flow to Resverlogix to keep the lights on.

Resverlogix can fail without affecting Zenith.

Koo

3 Recommendations

Apr 17, 2024 04:33PM

Apr 17, 2024 05:04PM

Apr 17, 2024 05:45PM

jonzobot

Apr 17, 2024 07:10PM

Apr 17, 2024 07:27PM

tada

Apr 18, 2024 12:30AM

Apr 18, 2024 05:25AM

Apr 18, 2024 09:20AM

Apr 21, 2024 05:44AM

Apr 21, 2024 07:37AM